134 related articles for article (PubMed ID: 3116449)
21. Reduced high-affinity agonist binding at the M(1) muscarinic receptor in Alzheimer's disease brain: differential sensitivity to agonists and divalent cations.
Ladner CJ; Lee JM
Exp Neurol; 1999 Aug; 158(2):451-8. PubMed ID: 10415152
[TBL] [Abstract][Full Text] [Related]
22. Guanine nucleotide regulation of a mammalian myocardial muscarinic receptor system. Evidence for homo- and heterotropic cooperativity in ligand binding analyzed by computer-assisted curve fitting.
Mattera R; Pitts BJ; Entman ML; Birnbaumer L
J Biol Chem; 1985 Jun; 260(12):7410-21. PubMed ID: 3838988
[TBL] [Abstract][Full Text] [Related]
23. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
Watson M; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580
[TBL] [Abstract][Full Text] [Related]
24. Interactions between the muscarinic receptors, sodium channels, and guanine nucleotide-binding protein(s) in rat atria.
Cohen-Armon M; Sokolovsky M
J Biol Chem; 1986 Sep; 261(27):12498-505. PubMed ID: 2427520
[TBL] [Abstract][Full Text] [Related]
25. M2-muscarinic receptors: how does ligand binding affinity relate to intrinsic activity?
Van Gelderen JG; Daeffler L; Scherrer D; Mousli M; Landry Y; Gies JP
J Recept Signal Transduct Res; 1996; 16(1-2):135-48. PubMed ID: 8771535
[TBL] [Abstract][Full Text] [Related]
26. Solubilization and characterization of guanine nucleotide-sensitive muscarinic agonist binding sites from rat myocardium.
Berrie CP; Birdsall NJ; Hulme EC; Keen M; Stockton JM
Br J Pharmacol; 1984 Aug; 82(4):853-61. PubMed ID: 6478115
[TBL] [Abstract][Full Text] [Related]
27. Irreversible binding of acetylethylcholine mustard to cardiac cholinergic muscarinic receptors.
Baker SP; Posner P
Mol Pharmacol; 1986 Nov; 30(5):411-8. PubMed ID: 3773882
[TBL] [Abstract][Full Text] [Related]
28. Reconstitution of the muscarinic acetylcholine receptor. Guanine nucleotide-sensitive high affinity binding of agonists to purified muscarinic receptors reconstituted with GTP-binding proteins (Gi and Go).
Haga K; Haga T; Ichiyama A
J Biol Chem; 1986 Aug; 261(22):10133-40. PubMed ID: 3015919
[TBL] [Abstract][Full Text] [Related]
29. Reciprocal modulation of agonist and antagonist binding to A1 adenosine receptors by guanine nucleotides is mediated via a pertussis toxin-sensitive G protein.
Ramkumar V; Stiles GL
J Pharmacol Exp Ther; 1988 Sep; 246(3):1194-200. PubMed ID: 3138408
[TBL] [Abstract][Full Text] [Related]
30. Bretylium tosylate binds preferentially to muscarinic receptors labelled with [3H]oxotremorine M (SH or 'high affinity' receptors) in rat heart and brain cortex.
Gillard M; Brunner F; Waelbroeck M; Svoboda M; Christophe J
Eur J Pharmacol; 1989 Jan; 160(1):117-24. PubMed ID: 2714357
[TBL] [Abstract][Full Text] [Related]
31. Effects of halothane and other chlorinated hydrocarbons on alpha 2-adrenoceptors in the mouse cortex.
Wikberg JE; Hede AR; Post C
Pharmacol Toxicol; 1987 Nov; 61(5):271-7. PubMed ID: 2830609
[TBL] [Abstract][Full Text] [Related]
32. Interaction of a radiolabeled agonist with cardiac muscarinic cholinergic receptors.
Harden TK; Meeker RB; Martin MW
J Pharmacol Exp Ther; 1983 Dec; 227(3):570-7. PubMed ID: 6317839
[TBL] [Abstract][Full Text] [Related]
33. Muscarinic binding sites on bovine pulmonary arterial endothelial cells in culture.
Aronstam RS; Ryan US; Catravas JD
Pharmacology; 1992; 44(6):324-33. PubMed ID: 1508962
[TBL] [Abstract][Full Text] [Related]
34. Muscarinic acetylcholine receptors in the sino-atrial node and right atrium of bovine heart.
Braun AP; Phan TD; Sulakhe PV
Eur J Pharmacol; 1990 Sep; 189(2-3):201-15. PubMed ID: 2253703
[TBL] [Abstract][Full Text] [Related]
35. Differential inhibition of [3H]-oxotremorine-M and [3H]-quinuclinidyl benzilate binding to muscarinic receptors in rat brain membranes with acetylcholinesterase inhibitors.
Lockhart B; Closier M; Howard K; Steward C; Lestage P
Naunyn Schmiedebergs Arch Pharmacol; 2001 Apr; 363(4):429-38. PubMed ID: 11330337
[TBL] [Abstract][Full Text] [Related]
36. Interactions of cocaine with primary and secondary recognition sites on muscarinic receptors.
Flynn DD; Vaishnav AA; Mash DC
Mol Pharmacol; 1992 Apr; 41(4):736-42. PubMed ID: 1569924
[TBL] [Abstract][Full Text] [Related]
37. The binding of a 2-chloroethylamine derivative of oxotremorine (BM 123) to muscarinic receptors in the rat cerebral cortex.
Ehlert FJ; Jenden DJ
Mol Pharmacol; 1985 Aug; 28(2):107-19. PubMed ID: 3839562
[TBL] [Abstract][Full Text] [Related]
38. Changes in 3H-quinuclidinyl benzilate binding and protein synthesis in the striatum following chronic administrations of muscarinic agonist.
Honda K; Takano Y; Kamiya H
Jpn J Pharmacol; 1995 Jan; 67(1):83-6. PubMed ID: 7745849
[TBL] [Abstract][Full Text] [Related]
39. Comparison of effects of MgCl2 and Gpp(NH)p on antagonist and agonist radioligand binding to adenosine A1 receptors.
Finlayson K; Maemoto T; Butcher SP; Sharkey J; Olverman HJ
Acta Pharmacol Sin; 2003 Aug; 24(8):729-40. PubMed ID: 12904270
[TBL] [Abstract][Full Text] [Related]
40. Presynaptic muscarinic receptors on dopaminergic terminals in the nucleus accumbens.
De Belleroche J; Kilpatrick IC; Birdsall NJ; Hulme EC
Brain Res; 1982 Feb; 234(2):327-37. PubMed ID: 7059834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]